Health Canada approves drug that treats hot flashes for use by breast cancer patients CTV NewsMuna Al-Khaifi: A New Non-Hormonal Option for Vasomotor Symptoms in Breast Cancer Survivors OncodailyLYNKUET® (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer Business Wire
